RALLYBIO CORPORATION Accrued Income Taxes, Current
RALLYBIO CORPORATION (RLYB) had Accrued Income Taxes, Current of $1.27 million as of 2026-06-30, per its S-4/A filed 2026-08-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-26
- 2026-06-30: Accrued Income Taxes, Current $1.27M.
- 2025-12-31: Accrued Income Taxes, Current $0.00.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $1.27M S-4/A · filed 2026-08-26 |
| 2025-12-31 | $0.00 S-4/A · filed 2026-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |